Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rowe

Showing results (551-560 of 632) with videos related to

Pageof 64
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 17, 2018
Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to ArmsRoberto A Salas Fragomeni, Tali Amir, Sara Sheikhbahaei, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 28, 2019
Prospective Comparison of PET Imaging with PSMA-Targeted <sup>18</sup>F-DCFPyL Versus Na<sup>18</sup>F for Bone Lesion Detection in Patients with Metastatic Prostate CancerSteven P Rowe, Xin Li, Bruce J Trock, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 3, 2017
Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imagingSara Sheikhbahaei, Ali Afshar-Oromieh, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 7, 2024
Prognostic Performance of RECIP 1.0 Based on [<sup>18</sup>F]PSMA-1007 PET in Prostate Cancer Patients Treated with [<sup>177</sup>Lu]Lu-PSMA I&TPhilipp E Hartrampf, Thomas Hüttmann, Anna Katharina Seitz, et al.
Clinical Nuclear Medicine|February 15, 2019
Novel Functional Renal PET Imaging With 18F-FDS in Human SubjectsRudolf A Werner, Alvaro A Ordonez, Julian Sanchez-Bautista, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 8, 2018
Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on <sup>18</sup>F-DCFPyL PET/CT ImagingRudolf A Werner, Ralph A Bundschuh, Lena Bundschuh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2024
RECIP 1.0 Predicts Progression-Free Survival After [<sup>177</sup>Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate CancerAndrei Gafita, Loic Djaileb, Isabel Rauscher, et al.
Frontiers in Oncology|June 28, 2019
[<sup>68</sup>Ga]-Pentixafor PET/CT for CXCR4-Mediated Imaging of Vestibular SchwannomasMaria Breun, Camelia M Monoranu, Almuth F Kessler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 22, 2020
<sup>11</sup>C-PABA as a PET Radiotracer for Functional Renal Imaging: Preclinical and First-in-Human StudyCamilo A Ruiz-Bedoya, Alvaro A Ordonez, Rudolf A Werner, et al.
Blood|April 1, 2024
Axicabtagene ciloleucel vs standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volumeFrederick L Locke, Olalekan O Oluwole, John Kuruvilla, et al.
Pageof 64

Showing results (551-560 of 632) with videos related to

Sort By:
Pageof 64
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 17, 2018
Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to ArmsRoberto A Salas Fragomeni, Tali Amir, Sara Sheikhbahaei, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 28, 2019
Prospective Comparison of PET Imaging with PSMA-Targeted <sup>18</sup>F-DCFPyL Versus Na<sup>18</sup>F for Bone Lesion Detection in Patients with Metastatic Prostate CancerSteven P Rowe, Xin Li, Bruce J Trock, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 3, 2017
Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imagingSara Sheikhbahaei, Ali Afshar-Oromieh, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 7, 2024
Prognostic Performance of RECIP 1.0 Based on [<sup>18</sup>F]PSMA-1007 PET in Prostate Cancer Patients Treated with [<sup>177</sup>Lu]Lu-PSMA I&TPhilipp E Hartrampf, Thomas Hüttmann, Anna Katharina Seitz, et al.
Clinical Nuclear Medicine|February 15, 2019
Novel Functional Renal PET Imaging With 18F-FDS in Human SubjectsRudolf A Werner, Alvaro A Ordonez, Julian Sanchez-Bautista, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 8, 2018
Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on <sup>18</sup>F-DCFPyL PET/CT ImagingRudolf A Werner, Ralph A Bundschuh, Lena Bundschuh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2024
RECIP 1.0 Predicts Progression-Free Survival After [<sup>177</sup>Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate CancerAndrei Gafita, Loic Djaileb, Isabel Rauscher, et al.
Frontiers in Oncology|June 28, 2019
[<sup>68</sup>Ga]-Pentixafor PET/CT for CXCR4-Mediated Imaging of Vestibular SchwannomasMaria Breun, Camelia M Monoranu, Almuth F Kessler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 22, 2020
<sup>11</sup>C-PABA as a PET Radiotracer for Functional Renal Imaging: Preclinical and First-in-Human StudyCamilo A Ruiz-Bedoya, Alvaro A Ordonez, Rudolf A Werner, et al.
Blood|April 1, 2024
Axicabtagene ciloleucel vs standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volumeFrederick L Locke, Olalekan O Oluwole, John Kuruvilla, et al.
Pageof 64